[1] 中华医学会神经病学分会帕金森病及运动障碍学组. 中国帕金森病治疗指南(第三版)[J].中华神经科杂志, 2014(6):428-433. [2] Maxwell CJ, Campitelli MA, Hogan DB,et al. Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition[J].Pharmacoepidemiol Drug Saf,2018, 27(3): 289-298. [3] Lapeyre-Mestre M. A review of adverse outcomes associated with psychoactive drug use in nursing home residents with dementia[J].Drugs Aging,2016, 33(12): 865-888. [4] 陈伶,孙奕.帕金森病常见精神障碍的临床表现及药物治疗[J].实用老年医学,2014,28(04):338-340. [5] Waade RB, Molden E, Martinsen MI, et al. Psychotropics and weak opioid analgesics in plasma samples of older hip fracture patients - detection frequencies and consistency with drug records[J].Br J Clin Pharmacol,2017, 83(7):1397-1404. [6] 李丽霞,朴英善,余舒扬,扈杨,左丽君,余秋瑾,王瑞丹,连腾宏,杜阳,张巍.帕金森病伴发认知障碍患者的营养状况及其影响因素分析[J].实用老年医学,2016,30(07):588-591. [7] Leavy B, Michaelsson K, Aberg AC, et al. The impact of disease and drugs on hip fracture risk[J].Calcif Tissue Int,2017, 100(1): 1-12. [8] Van Leeuwen E, Petrovic M, van Driel ML, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia[J].Cochrane Database Syst Rev,2018,3:CD007726.
2018, Vol. 35 
